MeSH tree: C10.228.662.600
Scientists have long studied the role of dopamine, a chemical in the brain that helps control learning and movement, in order to better understand Parkinson's disease, schizophrenia, and depression—afflictions caused, in ...
Mar 25, 2026
0
15
Doctors often struggle to distinguish early dementia with Lewy bodies from early Parkinson's disease. The two neurological conditions share many symptoms, including changes in movement, and are frequently misdiagnosed in ...
Mar 24, 2026
0
4
Our ability to feel a harmful touch or sense dangerous heat relies on specialized receptor proteins embedded in nerve cell membranes. But how do these receptors maintain their exquisite sensitivity? In a new study, researchers ...
Mar 24, 2026
0
2
An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent publication in the journal Nature Medicine, they describe the discovery of a new quantitative biomarker ...
Mar 24, 2026
0
4
An international team led by the ITACA Institute at the Universitat Politècnica de València (UPV) has developed one of the most comprehensive and detailed structural atlases of the human brain to date. Known as HoliAtlas, ...
Mar 24, 2026
0
41
Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy, achieving the safe and efficient transplantation of healthy mitochondria into cells and tissues for the first ...
Mar 23, 2026
0
43
In a study published in eNeuro, Lena Ting, from Emory University, and colleagues explored how brain and muscle activity during balance recovery change due to aging and Parkinson's. Previously, Ting's research group revealed ...
Mar 23, 2026
0
7
New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University of Essex. Using artificial ...
Mar 19, 2026
0
14
A Boston University-led research team has discovered a dopamine signal in the brain that helps determine whether you are moving toward or away from a goal, potentially shedding new light on how the brain uses visual information ...
Mar 19, 2026
0
29
Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), simultaneously targets ...
Mar 18, 2026
0
17
